ReviewCureus2022

Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review.

Maurice H Dick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.